FTO-Dependent N6-Methyladenosine Regulates Cardiac Function During Remodeling and Repair P Mathiyalagan, M Adamiak, J Mayourian, Y Sassi, Y Liang, N Agarwal, ... Circulation 139 (4), 518-532, 2019 | 506 | 2019 |
MiR-378 controls cardiac hypertrophy by combined repression of mitogen-activated protein kinase pathway factors J Ganesan, D Ramanujam, Y Sassi, A Ahles, C Jentzsch, S Werfel, ... Circulation 127 (21), 2097-2106, 2013 | 267 | 2013 |
Cardiac myocyte miR-29 promotes pathological remodeling of the heart by activating Wnt signaling Y Sassi, P Avramopoulos, D Ramanujam, L Grüter, S Werfel, S Giosele, ... Nature communications 8 (1), 1614, 2017 | 228 | 2017 |
Pkm2 regulates cardiomyocyte cell cycle and promotes cardiac regeneration A Magadum, N Singh, AA Kurian, I Munir, T Mehmood, K Brown, ... Circulation 141 (15), 1249-1265, 2020 | 207 | 2020 |
Critical role for stromal interaction molecule 1 in cardiac hypertrophy JS Hulot, J Fauconnier, D Ramanujam, A Chaanine, F Aubart, Y Sassi, ... Circulation 124 (7), 796-805, 2011 | 189 | 2011 |
Multidrug resistance-associated protein 4 regulates cAMP-dependent signaling pathways and controls human and rat SMC proliferation Y Sassi, L Lipskaia, G Vandecasteele, VO Nikolaev, SN Hatem, FC Aubart, ... The Journal of clinical investigation 118 (8), 2747-2757, 2008 | 152 | 2008 |
A phenotypic screen to identify hypertrophy-modulating microRNAs in primary cardiomyocytes C Jentzsch, S Leierseder, X Loyer, I Flohrschütz, Y Sassi, D Hartmann, ... Journal of molecular and cellular cardiology 52 (1), 13-20, 2012 | 147 | 2012 |
Ryanodine receptor leak mediated by caspase-8 activation leads to left ventricular injury after myocardial ischemia-reperfusion J Fauconnier, AC Meli, J Thireau, S Roberge, J Shan, Y Sassi, SR Reiken, ... Proceedings of the National Academy of Sciences 108 (32), 13258-13263, 2011 | 136 | 2011 |
Inhibition of MRP4 prevents and reverses pulmonary hypertension in mice Y Hara, Y Sassi, C Guibert, N Gambaryan, P Dorfmüller, S Eddahibi, ... The Journal of clinical investigation 121 (7), 2888-2897, 2011 | 119 | 2011 |
Cyclic nucleotide compartmentalization: contributions of phosphodiesterases and ATP-binding cassette transporters S Cheepala, JS Hulot, JA Morgan, Y Sassi, W Zhang, AP Naren, ... Annual review of pharmacology and toxicology 53, 231-253, 2013 | 116 | 2013 |
RNA interference targeting STIM1 suppresses vascular smooth muscle cell proliferation and neointima formation in the rat FC Aubart, Y Sassi, A Coulombe, N Mougenot, C Vrignaud, P Leprince, ... Molecular Therapy 17 (3), 455-462, 2009 | 109 | 2009 |
microRNA-22 promotes heart failure through coordinate suppression of PPAR/ERR-nuclear hormone receptor transcription P Gurha, T Wang, AH Larimore, Y Sassi, C Abreu-Goodger, MO Ramirez, ... PLoS One 8 (9), e75882, 2013 | 100 | 2013 |
Deletion of delta-like 1 homologue accelerates fibroblast–myofibroblast differentiation and induces myocardial fibrosis P Rodriguez, Y Sassi, L Troncone, L Benard, K Ishikawa, RE Gordon, ... European heart journal 40 (12), 967-978, 2019 | 94 | 2019 |
Cardiac myocyte–secreted cAMP exerts paracrine action via adenosine receptor activation Y Sassi, A Ahles, DJJ Truong, Y Baqi, SY Lee, B Husse, JS Hulot, ... The Journal of clinical investigation 124 (12), 5385-5397, 2014 | 94 | 2014 |
Regulation of cAMP homeostasis by the efflux protein MRP4 in cardiac myocytes Y Sassi, A Abi-Gerges, J Fauconnier, N Mougenot, S Reiken, K Haghighi, ... The FASEB Journal 26 (3), 1009, 2012 | 85 | 2012 |
Viral vector-based targeting of miR-21 in cardiac nonmyocyte cells reduces pathologic remodeling of the heart D Ramanujam, Y Sassi, B Laggerbauer, S Engelhardt Molecular Therapy 24 (11), 1939-1948, 2016 | 73 | 2016 |
SERCA2a controls the mode of agonist-induced intracellular Ca2+ signal, transcription factor NFAT and proliferation in human vascular smooth muscle cells R Bobe, L Hadri, JJ Lopez, Y Sassi, F Atassi, I Karakikes, L Liang, I Limon, ... Journal of molecular and cellular cardiology 50 (4), 621-633, 2011 | 67 | 2011 |
Regulation of the methylation and expression levels of the BMPR2 gene by SIN3a as a novel therapeutic mechanism in pulmonary arterial hypertension M Bisserier, P Mathiyalagan, S Zhang, F Elmastour, P Dorfmüller, ... Circulation 144 (1), 52-73, 2021 | 58 | 2021 |
MRP4 (ABCC4) as a potential pharmacologic target for cardiovascular disease T Belleville-Rolland, Y Sassi, B Decouture, E Dreano, JS Hulot, ... Pharmacological research 107, 381-389, 2016 | 53 | 2016 |
Pulmonary artery hypertension model in rats by monocrotaline administration C Bueno-Beti, Y Sassi, RJ Hajjar, L Hadri Experimental Models of Cardiovascular Diseases: Methods and Protocols, 233-241, 2018 | 41 | 2018 |